You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glucocerebrosidase

Showing 1 - 25 of 78
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GCase Activity to IdentifySubpopulation Eligible forTherapeutic

Not yet recruiting
  • Dementia With Lewy Bodies
  • Glucocerebrosidase
  • GBA gene
  • (no location specified)
Mar 21, 2022

Positron Emission Tomography Imaging in People With Gaucher

Completed
  • Parkinson Disease
  • Gaucher Disease
  • 15-0 H20
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 18, 2023

Parkinsons Disease Trial (Blood Brain Barrier Disruption - Functional)

Not yet recruiting
  • Parkinsons Disease
  • Blood Brain Barrier Disruption - Functional
  • (no location specified)
Sep 29, 2022

Gaucher Disease, Type 1 Trial in Worldwide (VPRIV ®,)

Completed
Has Results
  • Gaucher Disease, Type 1
  • VPRIV ®,
  • Buenos Aires, Argentina
  • +4 more
Jun 28, 2021

Local Field Potential Data onSubgroup of Parkinson's Disease

Completed
  • Parkinson Disease
  • collection of LFPs
  • Chicago, Illinois
    Rush University Medical Center
Jul 8, 2021

Gaucher Disease, Type 1 Trial in Worldwide (velaglucerase alfa, imiglucerase)

Completed
Has Results
  • Gaucher Disease, Type 1
  • velaglucerase alfa
  • imiglucerase
  • Durham, North Carolina
  • +10 more
May 14, 2021

Gaucher Disease Trial in Hamamatsu, Minato-ku, Osaka (velaglucerase alfa)

Completed
Has Results
  • Gaucher Disease
  • velaglucerase alfa
  • Hamamatsu, Shizuoka, Japan
  • +2 more
Jun 25, 2021

Gaucher Disease Trial in Worldwide (GA-GCB (velaglucerase alfa))

Completed
Has Results
  • Gaucher Disease
  • GA-GCB (velaglucerase alfa)
  • Los Angeles, California
  • +14 more
May 26, 2021

Gaucher Disease Trial in Jerusalem, Bucharest, Belgrade (GA-GCB)

Completed
Has Results
  • Gaucher Disease
  • Jerusalem, Israel
  • +2 more
May 30, 2021

Parkinson's Disease Trial in Worldwide (BIA 28-6156 10 mg, BIA 28-6156 60 mg, Placebo)

Recruiting
  • Parkinson's Disease
  • BIA 28-6156 10 mg
  • +2 more
  • Los Angeles, California
  • +73 more
Apr 18, 2023

Parkinson Disease, GBA Gene Mutation Trial in Milan, Naples, Pavia (Ambroxol Hydrochloride, Placebo)

Recruiting
  • Parkinson Disease
  • GBA Gene Mutation
  • Ambroxol Hydrochloride
  • Placebo
  • Milan, Italy
  • +2 more
Mar 10, 2022

Parkinson's Disease Trial in Worldwide (venglustat GZ/SAR402671, Placebo)

Terminated
Has Results
  • Parkinson's Disease
  • venglustat GZ/SAR402671
  • Placebo
  • Scottsdale, Arizona
  • +51 more
May 3, 2022

Parkinson, Parkinson Disease Trial in Groningen (Ambroxol Hydrochloride, Placebo)

Recruiting
  • Parkinson
  • Parkinson Disease
  • Ambroxol Hydrochloride
  • Placebo
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 13, 2023

Determine Mutations in Gaucher Gene in Idiopathic Parkinson's

Completed
  • Parkinson Disease
  • Idiopathic Parkinson Disease
    • Bad Neustadt An Der Saale, Germany
    • +14 more
    Apr 8, 2021

    Genetic Studies of Lysosomal Storage Disorders

    Enrolling by invitation
    • Lysosomal Storage Disorders
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Parkinson Disease Trial (Ambroxol Hydrochloride (420mg), Placebo)

      Not yet recruiting
      • Parkinson Disease
      • Ambroxol Hydrochloride (420mg)
      • Placebo
      • (no location specified)
      Mar 9, 2023

      Gaucher Disease, Type 3 Trial (Gene therapy, Enzyme Replacement Agent)

      Not yet recruiting
      • Gaucher Disease, Type 3
      • Gene therapy
      • Enzyme Replacement Agent
      • (no location specified)
      Apr 14, 2023

      Gaucher Disease, Type 1 Trial in Jerusalem (Ambroxol)

      Active, not recruiting
      • Gaucher Disease, Type 1
      • Jerusalem, Israel
        Shaare Zedek Medical Center
      May 24, 2022

      Neurological Manifestations in Gaucher Disease Patients

      Not yet recruiting
      • Gaucher Disease
        • (no location specified)
        Apr 14, 2023

        Gaucher Disease Trial in Durham, Fairfax (LY3884961, Methylprednisolone, Sirolimus)

        Not yet recruiting
        • Gaucher Disease
        • LY3884961
        • +3 more
        • Durham, North Carolina
        • +1 more
        Aug 1, 2022

        Parkinson Disease and DBS: Cognitive Effects in GBA Mutation

        Recruiting
        • Parkinson
        • +4 more
        • cognitive assessments
        • New Brunswick, New Jersey
          Rutgers-RWJ University Hospital
        Jul 8, 2021

        Gaucher Disease Trial in Australia, Canada, United States (AVR-RD-02)

        Recruiting
        • Gaucher Disease
        • Iowa City, Iowa
        • +2 more
        Oct 20, 2022

        Bone in Pediatric Gaucher Disease Related to Bone Pathology in

        Recruiting
        • Gaucher Disease
        • Bone Diseases
          • Fairfax, Virginia
            Lysosomal and Rare disorder research and treatment center
          Nov 6, 2023

          Pediatric Patients With Unexplained Enlarged Spleen

          Recruiting
          • Gaucher Disease, Splenomegaly
          • Acid SphingoMyelinase Deficiency
            • Amiens, France
            • +39 more
            Aug 19, 2022

            Dementia With Lewy Bodies Trial in Haugesund (Ambroxol, Placebo)

            Recruiting
            • Dementia With Lewy Bodies
            • Haugesund, Norway
              Helse Fonna
            May 18, 2021